RX.HA.25mg+ (Intense Volume)
Hyaluronic-acid volumizing filler; not identified as a PLLA product in the NEES Medical catalogue.
Exact-name product discovery for clinics comparing collagen stimulators, hybrid PLA + HA products and high-volume HA fillers. These categories are related in buyer searches, but they are not interchangeable.
RX.HA.25mg+ (Intense Volume) is described in the live catalogue as a 25 mg/ml hyaluronic-acid volumizing filler, not as PLLA.
PLA + HA Filler and PLA + HA Soft Tissue Injectable Implant are hybrid professional listings. Confirm whether the supplied label states PLA, PDLLA or PLLA; those terms should not be silently treated as identical.
Hyaluronic-acid volumizing filler; not identified as a PLLA product in the NEES Medical catalogue.
Hybrid PLA/PLLA-category and hyaluronic-acid professional product; confirm the exact labelled polymer and composition on the supplied pack.
Hybrid PLA/PLLA-category and hyaluronic-acid professional product; confirm the exact labelled polymer and composition on the supplied pack.
No. The current NEES Medical catalogue describes RX.HA.25mg+ Intense Volume as a 25 mg/ml hyaluronic-acid volumizing filler. It should not be grouped clinically with PLLA or PLA + HA products.
PLLA is used as a broad search term for lactic-acid-polymer collagen stimulators. A PLA + HA hybrid combines a labelled PLA-family polymer with hyaluronic acid. Exact polymer identity, composition, preparation and evidence are product-specific and must be checked on current manufacturer documentation.
Confirm the exact trade name, manufacturer, labelled composition, sealed packaging, lot, expiry, storage history, invoice and sourcing documents. Product selection and administration must be handled by an appropriately licensed practitioner.